RNF113B

gene
On this page

Also known as RNF161

Summary

RNF113B (ring finger protein 113B, HGNC:17267) is a protein-coding gene on chromosome 13q32.2, encoding RING finger protein 113B (Q8IZP6).

Predicted to enable zinc ion binding activity. Predicted to be involved in snoRNA splicing. Predicted to be part of U2-type spliceosomal complex.

Source: NCBI Gene 140432 — RefSeq curated summary.

At a glance

  • GWAS associations: 2
  • MANE Select transcript: NM_178861

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:17267
Approved symbolRNF113B
Namering finger protein 113B
Location13q32.2
Locus typegene with protein product
StatusApproved
AliasesRNF161
Ensembl geneENSG00000139797
Ensembl biotypeprotein_coding
Entrez140432

Gene structure

Transcript identifiers

Ensembl transcripts: 1 — 1 protein_coding

ENST00000267291

RefSeq mRNA: 1 — MANE Select: NM_178861 NM_178861

CCDS: CCDS9486

Canonical transcript exons

ENST00000267291 — 2 exons

ExonStartEnd
ENSE000009402229817628298177269
ENSE000013734819817578598176176

Expression profiles

Bgee: expression breadth broad, 29 present calls, max score 90.50.

FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.1374 / max 121.3419, expressed in 6 samples.

FANTOM5 promoters (2 alternative TSS)

Promoter IDTPM avgSamples expressed
1379140.11204
1379130.02544

Top tissues by expression

108 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
left testisUBERON:000453390.50gold quality
testisUBERON:000047390.09gold quality
right testisUBERON:000453489.59gold quality
quadriceps femorisUBERON:000137784.52gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099183.73gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047381.71gold quality
cerebellar vermisUBERON:000472075.34gold quality
adrenal tissueUBERON:001830359.31gold quality
thymusUBERON:000237058.79silver quality
calcaneal tendonUBERON:000370149.51silver quality
colonic epitheliumUBERON:000039748.18silver quality
liverUBERON:000210745.20silver quality
kidneyUBERON:000211342.82silver quality
tonsilUBERON:000237242.66gold quality
bloodUBERON:000017842.28silver quality
right lobe of liverUBERON:000111442.27silver quality
prostate glandUBERON:000236742.11gold quality
bone marrow cellCL:000209240.56gold quality
adult mammalian kidneyUBERON:000008240.52gold quality
monocyteCL:000057640.20silver quality
skeletal muscle tissueUBERON:000113439.98gold quality
lower esophagus mucosaUBERON:003583439.77gold quality
leukocyteCL:000073839.60gold quality
bone marrowUBERON:000237139.05gold quality
cortex of kidneyUBERON:000122538.40silver quality
adrenal glandUBERON:000236937.43gold quality
ganglionic eminenceUBERON:000402337.34gold quality
muscle tissueUBERON:000238537.10gold quality
hindlimb stylopod muscleUBERON:000425237.05silver quality
cortical plateUBERON:000534336.47gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no1.78

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

11 targeting RNF113B, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-6867-5P100.0082.213464
HSA-MIR-7110-3P100.0073.182486
HSA-MIR-450B-5P99.9271.483175
HSA-MIR-311999.9271.342390
HSA-MIR-1213099.7565.47452
HSA-MIR-6734-3P99.1566.271627
HSA-MIR-758-3P98.4268.601122
HSA-MIR-876-5P97.9968.491345
HSA-MIR-510-5P97.6665.82916
HSA-MIR-316796.8167.091236
HSA-MIR-550B-3P95.4367.73599

Cross-species orthologs

3 orthologs

OrganismSymbolGene ID
danio_reriornf113aENSDARG00000037930
drosophila_melanogastermdlcFBGN0038772
caenorhabditis_elegansWBGENE00010476

Paralogs (1): RNF113A (ENSG00000125352)

Protein

Protein identifiers

RING finger protein 113BQ8IZP6 (reviewed: Q8IZP6)

Alternative names: Zinc finger protein 183-like 1

All UniProt accessions (1): Q8IZP6

RefSeq proteins (1): NP_849192* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR000571Znf_CCCHDomain
IPR001841Znf_RINGDomain
IPR013083Znf_RING/FYVE/PHDHomologous_superfamily
IPR017907Znf_RING_CSConserved_site
IPR036855Znf_CCCH_sfHomologous_superfamily
IPR039971CWC24-likeFamily

Pfam: PF00642, PF13920

UniProt features (13 total): strand 4, zinc finger region 2, helix 2, chain 1, region of interest 1, compositionally biased region 1, sequence variant 1, sequence conflict 1

Structure

Experimental structures (PDB)

1 structures.

PDBMethodResolution (Å)
2CSYSOLUTION NMR

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q8IZP6-F172.660.31

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 16 (showing top): GOBP_RNA_SPLICING, chr13q32, GOCC_U2_TYPE_SPLICEOSOMAL_COMPLEX, GOCC_SPLICEOSOMAL_COMPLEX, GOCC_RIBONUCLEOPROTEIN_COMPLEX, GOMF_ACYLTRANSFERASE_ACTIVITY, GOMF_AMINOACYLTRANSFERASE_ACTIVITY, GOBP_MRNA_PROCESSING, MIR6867_5P, MIR450B_5P, MIR758_3P, GOCC_NUCLEAR_PROTEIN_CONTAINING_COMPLEX, GOBP_MRNA_METABOLIC_PROCESS, GSE4984_LPS_VS_VEHICLE_CTRL_TREATED_DC_UP, GOBP_RNA_SPLICING_VIA_TRANSESTERIFICATION_REACTIONS

GO Biological Process (1): snoRNA splicing (GO:0034247)

GO Molecular Function (2): zinc ion binding (GO:0008270), metal ion binding (GO:0046872)

GO Cellular Component (1): U2-type spliceosomal complex (GO:0005684)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
RNA splicing1
sno(s)RNA processing1
transition metal ion binding1
cation binding1
spliceosomal complex1

Protein interactions and networks

STRING

1475 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
RNF113BFARP1Q9Y4F1571
RNF113BDCAF12Q5T6F0542
RNF113BDCAF12L2Q5VW00475
RNF113BZIC5Q96T25447
RNF113BDOCK9Q9BZ29447
RNF113BTRIM74Q86UV6432
RNF113BPOM121L2Q96KW2418
RNF113BTRIM73Q86UV7417
RNF113BUBAC2Q8NBM4414
RNF113BTMEM278A6NKF7400
RNF113BUGGT2Q9NYU1390
RNF113BCYB5D1Q6P9G0382
RNF113BRFPL4AA6NLU0376
RNF113BRNF141Q8WVD5372
RNF113BTRIML1Q8N9V2370

IntAct

5 interactions, top by confidence:

ABTypeScore
RNF113BH1-4psi-mi:“MI:0915”(physical association)0.400
RNF113BUBE2L3psi-mi:“MI:0915”(physical association)0.370
UBE2R2RNF113Bpsi-mi:“MI:0915”(physical association)0.370
RNF113BUBE2Hpsi-mi:“MI:0915”(physical association)0.370

BioGRID (9): RNF113B (Co-fractionation), RNF113B (Proximity Label-MS), GIT1 (Affinity Capture-MS), RNF113A (Affinity Capture-MS), RNF113B (Proximity Label-MS), RNF113B (Two-hybrid), RNF113B (Two-hybrid), RNF113B (Two-hybrid), RNF113B (Two-hybrid)

ESM2 similar proteins: A2XIP9, A5GFW7, B1WB17, B4FGS2, E1C760, E7EXT2, F7AEX0, O15541, O59800, P0CR50, P0CR51, P28518, P35251, P35600, P35601, P35728, P52012, Q0VCR1, Q10154, Q21755, Q28E45, Q2R2B4, Q3LSS0, Q3T1J8, Q4P400, Q4R594, Q5AX35, Q5AXT6, Q5EAW4, Q5FVF1, Q5R9P9, Q5ZJN1, Q640E9, Q67ER4, Q6C3L4, Q70Z53, Q75LU5, Q810J8, Q8BP78, Q8IZP6

Diamond homologs: O15541, O17917, P0CQ64, P0CQ65, P53769, Q02398, Q1JPS1, Q4P400, Q4WUA0, Q55G16, Q5ACW2, Q5AVC5, Q67ER4, Q6BYU0, Q6CB23, Q6CSS6, Q6FXX1, Q6K4V3, Q752S4, Q7SDY3, Q8GX84, Q8IZP6, Q9FNG6, Q9P6R8, Q03605, O74747, G2Q0E2, P33288, Q1XHU0, Q6FPI4, Q6MFZ5, Q75EN0, Q7ZWF4, Q9ESN2, Q9HCM9, A0A3B3IT33, A4QPC6, A6NCK2, A6NDI0, A6NGJ6

SIGNOR signaling

1 interactions.

AEffectBMechanism
Ub:E2“up-regulates activity”RNF113Bubiquitination

Disease & clinical

Clinical variants and AI predictions

ClinVar

0 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance0
Likely benign0
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

87 predictions. Top by Δscore:

VariantEffectΔscore
13:98176274:G:Adonor_gain0.9300
13:98176278:CCACC:Cdonor_loss0.9300
13:98176279:CACC:Cdonor_loss0.9300
13:98176280:ACC:Adonor_loss0.9300
13:98176276:CCCCA:Cdonor_loss0.9200
13:98176277:CCCAC:Cdonor_loss0.9200
13:98176491:T:TAdonor_gain0.9200
13:98176485:T:TAdonor_gain0.9000
13:98176281:CCTT:Cdonor_gain0.8800
13:98176282:C:Gdonor_loss0.8700
13:98176178:T:Aacceptor_loss0.7600
13:98176290:G:GAdonor_gain0.7600
13:98176177:C:CCacceptor_gain0.6900
13:98176289:AG:Adonor_gain0.6600
13:98176172:TTTTC:Tacceptor_gain0.6200
13:98176175:TC:Tacceptor_gain0.6200
13:98176176:CC:Cacceptor_gain0.6200
13:98176174:TTC:Tacceptor_gain0.6100
13:98176506:T:TAdonor_gain0.6000
13:98176186:C:CTacceptor_gain0.5700
13:98176667:A:AGdonor_gain0.5700
13:98176499:T:TAdonor_gain0.5600
13:98176500:C:Adonor_gain0.5600
13:98176274:GCCC:Gdonor_loss0.5300
13:98176275:CCCC:Cdonor_loss0.5300
13:98176277:C:Tdonor_gain0.5300
13:98176283:T:Cdonor_loss0.5300
13:98176173:TTTC:Tacceptor_gain0.5200
13:98176273:TGCCC:Tdonor_loss0.5100
13:98176177:C:Tacceptor_gain0.4900

AlphaMissense

2135 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
13:98176598:G:CF213L0.988
13:98176598:G:TF213L0.988
13:98176600:A:GF213L0.988
13:98176412:G:CF275L0.986
13:98176412:G:TF275L0.986
13:98176414:A:GF275L0.986
13:98176437:A:TV267D0.985
13:98176616:G:CF207L0.985
13:98176616:G:TF207L0.985
13:98176618:A:GF207L0.985
13:98176646:C:AK197N0.968
13:98176646:C:GK197N0.968
13:98176368:C:GC290S0.964
13:98176369:A:TC290S0.964
13:98176448:G:CF263L0.964
13:98176448:G:TF263L0.964
13:98176450:A:GF263L0.964
13:98176625:G:CF204L0.964
13:98176625:G:TF204L0.964
13:98176627:A:GF204L0.964
13:98176335:A:GF301S0.963
13:98176413:A:CF275C0.962
13:98176413:A:GF275S0.962
13:98176334:A:CF301L0.960
13:98176334:A:TF301L0.960
13:98176336:A:GF301L0.960
13:98176425:C:GC271S0.956
13:98176426:A:TC271S0.956
13:98176418:A:CH273Q0.955
13:98176418:A:TH273Q0.955

dbSNP variants (sampled 300 via entrez): RS1000721301 (13:98177587 T>C), RS1002496351 (13:98175821 G>A,C), RS1003170212 (13:98178884 A>G,T), RS1003229314 (13:98179080 T>C), RS1006035214 (13:98177889 A>G), RS1006443207 (13:98176961 C>A,T), RS1007297013 (13:98176684 C>T), RS1009588146 (13:98175702 C>T), RS1009704630 (13:98175347 A>C), RS1014348290 (13:98175885 G>T), RS1017220859 (13:98179131 A>G), RS1018161527 (13:98177113 C>A,G,T), RS1018784426 (13:98178091 A>T), RS1020678119 (13:98175415 TATCCTTTATTTGCTGTTTTGGTAACTCTTGAACCCC>T), RS1022394689 (13:98175369 G>A)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

2 associations (top):

StudyTraitp-value
GCST002595_23Clozapine-induced agranulocytosis8.000000e-06
GCST009391_2024Metabolite levels3.000000e-06

EFO canonical traits (1, from GWAS)

EFO IDTrait name
EFO:0010371lysophosphatidylethanolamine 22:6 measurement

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

8 total (human), top 8 by PubMed support.

ChemicalActions (top 5)PubMed papers
tris(1,3-dichloro-2-propyl)phosphateincreases expression1
CGP 52608affects binding, increases reaction1
Resveratrolaffects cotreatment, decreases expression1
Sunitinibdecreases expression1
Benzo(a)pyreneincreases methylation1
Paraoxonincreases expression1
Plant Extractsaffects cotreatment, decreases expression1
Valproic Acidincreases methylation1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.